• WATCH THE INTERVIEW

    Val Romberg, CEO of Kedrion Biopharma, explains how our company is working on cultural change, and efficiency and business program improvements. Watch the interview online on "Le Fonti TV".

    Watch the interview

  • 2001-2021
    KEEP LIFE FLOWING

    Learn more

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

14-06-2021
World Blood Donor Day 2021, Kedrion pays tribute to the world of donors
A special edition for Italy, which is hosting the global World Blood Donor Day event
Read all
04-06-2021
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
26-04-2021
Kedrion supports World Primary Immunodeficiency Week
Early diagnosis and access to treatment to improve the quality of life of patients
Read all
2020 Annual report
Pharmacovigilance
Medical & Scientific Information